The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookies before using this site. Please see our Subscription Terms and Conditions.


All material subject to strictly enforced copyright laws. © 2021 Euromoney, a part of the Euromoney Institutional Investor PLC.
Capital Markets

Deals of the year 2009: M&A – Pfizer prepares for life after Lipitor

A big M&A deal was a no-brainer, but the Wyeth buyout was still a surprise.

Transaction value: $68.4 billion
Date: Announced January 2009, completed October 2009
Advisers to Pfizer: Bank of America Merrill Lynch, Goldman Sachs, JPMorgan, Barclays Capital, Citi
Advisers to Wyeth: Evercore, Morgan Stanley
Global coordinators: Goldman Sachs, HSBC, JPMorgan

Although secondary financial markets recovered strongly last year and primary debt and equity capital markets bankers were all kept busy, the shattered confidence of corporate management teams and investors was most evident in the collapse of M&A volume. Global volume totalled $2.4 trillion in 2009, the lowest since 2004 and down 24% on the $3.17

You have reached premium content. Please log in to continue reading.

Read beyond the headlines with Euromoney

For over 50 years, our readers have looked to Euromoney to stay informed about the issues that matter in the international banking and financial markets. Find out more about our different levels of access below.

SUBSCRIBE ONLINE TODAY

Unlimited access to Euromoney.com and Asiamoney.com

Expert comment, long reads and in-depth analysis interviews with senior finance professionals

Access the results of our market-leading annual surveys across core financial services

Access the results of our annual awards, including the world-renowned Awards for Excellence

Your print copy of Euromoney magazine delivered monthly

£73.75 per month

Billed Annually

FREE 7 DAY TRIAL

Unlimited access to Euromoney.com and Asiamoney.com, including our top stories, long reads, expert analysis, and the results of our annual surveys and awards

Sign up to any of our newsletters, curated by our editors

LOGIN NOW

Already a user?

We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree